Trial intelligence / Profile preview

Pharmacokinetics of cefoselis during continuous renal replacement therapy in critically ill patients

ChiCTR-OCH-14004869Phase 4Completed

Sponsor
First People's Hospital of Lianyungang City
Start
Jun 2012
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of cefoselis in kidney failure (2 arms), sponsored by First People's Hospital of Lianyungang City. Primary endpoint: Plasma drug concentration. Started Jun 2012; status: completed.

02

Drugs

cefoselis
03

Conditions

kidney failure

Beyond the preview

Go deeper on ChiCTR-OCH-14004869.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-OCH-14004869.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call